In Silico Design and Assessment of Coumarin Derivatives for Anticancer Activity
Biological Sciences · 2026
DOI: 10.55006/biolsciences.2026.6303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological Sciences, 2026. Verfasst von Ashish Pandey und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background/Objectives: Cancer remains one of the leading causes of mortality worldwide, demanding the discovery of safer and more effective therapeutic agents.
Methods
In this study, a comprehensive coumarin derivative library containing 2,681 compounds was compiled from literature and online chemical databases. After data refinement, duplicate removal, and application of drug-likeness filters, 1,800 compounds were selected for further analysis. These were screened through toxicity prediction and structure–activity relationship (SAR) studies, yielding 20 promising candidates with favorable pharmacokinetic and safety profiles. The shortlisted compounds were then evaluated in silico for their anticancer potential. Molecular docking was carried out using AutoDock Vina against human Topoisomerase IIα (PDB ID: 4FM9), a crucial enzyme involved in DNA replication and a validated target in cancer therapy. For comparative evaluation within the coumarin scaffold, the natural coumarin derivative scopoletin was also docked against the same protein under identical conditions.
Results
Among the designed compounds, L3 (–8.6 kcal/mol) and L12 (–8.8 kcal/mol) showed the strongest binding interactions, while scopoletin exhibited a binding energy of –7.8 kcal/mol. The improved binding affinity of the designed derivatives compared to scopoletin suggests that structural modifications of the coumarin nucleus enhanced their interaction with Topoisomerase IIα.
Conclusions
Overall, the study highlights coumarin scaffolds as promising leads for developing novel anticancer agents through structure-based optimization.
Zitieren
APA
Pandey, A., Yadav, A., Tiwari, A., Singh, A., Singh, A., & Vishwakarma, P. K. (2026). In Silico Design and Assessment of Coumarin Derivatives for Anticancer Activity. Biological Sciences. https://doi.org/10.55006/biolsciences.2026.6303
Vancouver
Pandey A, Yadav A, Tiwari A, Singh A, Singh A, Vishwakarma PK. In Silico Design and Assessment of Coumarin Derivatives for Anticancer Activity. Biological Sciences. 2026. doi:10.55006/biolsciences.2026.6303
BibTeX
@article{Pandey2026,
author = {Pandey, Ashish and Yadav, Anuvanshika and Tiwari, Anupam and Singh, Antima and Singh, Amrita and Vishwakarma, Pratik Kumar},
title = {In Silico Design and Assessment of Coumarin Derivatives for Anticancer Activity},
journal = {Biological Sciences},
year = {2026},
doi = {10.55006/biolsciences.2026.6303}
}
EUVIMED